In the second quarter of 2015, the value of takeovers in the pharmaceutical and biotech sector topped US$1 trillion. And now Montreal-based drug giant Valeant Pharmaceuticals is offering US$1 billion   Read More

Baby boomers may increasingly whine about their creaking bodies.  But a positive side to their groans and moans for healthcare solutions is the growing need for drugs — particularly prescription   Read More

Johnson & Johnson has gone through a spate of recent problems, but its size, earnings record, dividend record, productivity and R & D still make this healthcare solutions giant a   Read More